Skip to main content
profile image
Selected Works of John M. Pagel, MD, PhD
Article
Anti-CD45 Pretargeted Radioimmunotherapy using Bismuth-213: High Rates of Complete Remission and Long-Term Survival in a Mouse Myeloid Leukemia Xenograft Model
Blood (2011)
  • John M. Pagel, Fred Hutchinson Cancer Research Center
  • Aimee L. Kenoyer, Fred Hutchinson Cancer Research Center
  • Tom Bäck, University of Gothenburg
  • Donald K. Hamlin, University of Washington
  • D. Scott Wilbur, University of Washington
  • Darrell R. Fisher, Pacific Northwest National Laboratory
  • Steven I. Park, Fred Hutchinson Cancer Research Center
  • Shani Frayo, Fred Hutchinson Cancer Research Center
  • Amanda Axtman, Fred Hutchinson Cancer Research Center
  • Nural Orgun, Fred Hutchinson Cancer Research Center
  • Johnnie Orozco, Fred Hutchinson Cancer Research Center
  • Jaideep Shenoi, Fred Hutchinson Cancer Research Center
  • Yukang Lin, Fred Hutchinson Cancer Research Center
  • Ajay K. Gopal, Fred Hutchinson Cancer Research Center
  • Damian J. Green, Fred Hutchinson Cancer Research Center
  • Frederick R. Appelbaum, Fred Hutchinson Cancer Research Center
  • Oliver W. Press, Fred Hutchinson Cancer Research Center
Link
Disciplines
Publication Date
July 21, 2011
DOI
10.1182/blood-2011-04-347039
Citation Information
John M. Pagel, Aimee L. Kenoyer, Tom Bäck, Donald K. Hamlin, et al.. "Anti-CD45 Pretargeted Radioimmunotherapy using Bismuth-213: High Rates of Complete Remission and Long-Term Survival in a Mouse Myeloid Leukemia Xenograft Model" Blood Vol. 118 Iss. 3 (2011) p. 703 - 711
Available at: http://works.bepress.com/john-pagel/179/